My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2023-140
CBCC
>
Official Documents
>
2020's
>
2023
>
2023-140
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
8/4/2023 12:08:17 PM
Creation date
8/4/2023 12:06:37 PM
Metadata
Fields
Template:
Official Documents
Official Document Type
Agreement
Approved Date
07/11/2023
Control Number
2023-140
Agenda Item Number
8.T.
Entity Name
RxBenefits. Inc. f/k/a Prescription Benefits, Inc
Subject
Addendum to Administrative Service Agreement reflecting improved pricing
and updates effective January1, 2023
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
23
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
DocuSign Envelope ID: 5332467E-CBEF-4C5D-8BOE-61 E380BDA11 B <br />DocuSign Envelope ID: 151 ECOCF-B55C-414F-9455-72004347A310 <br />( 112023 Version) <br />■ Mail Order: Lower of (i) Plan copayments/coinsurance or (ii) discounted AWP (including MAC price, <br />when MAC pricing is applicable). <br />• If no adjudication rates are specified herein, each Prescription Drug Claim will be adjudicated to Client <br />at the applicable ingredient cost and will be reconciled to the applicable guarantee as set forth herein. <br />The discounted ingredient cost will be the lesser of MAC (as applicable), U&C or the applicable AWP <br />discount. Prescription Drug Claims dispensed at ESI Mail Pharmacy will be adjudicated to Client at the <br />applicable ingredient cost and will be reconciled to the applicable guarantee as set forth herein. <br />3.1 Pricing. <br />(a) Ingredient Cost. Administrator will offer an average aggregate annual discount as reflected below <br />on Client utilization to be calculated as follows. The pricing below will be implemented as of the <br />Addendum Effective Date. The pricing below will be guaranteed upon the start of Client's Renewal <br />Term (as described in the Agreement) that begins on or after the Addendum Effective Date. <br />[]-(total discounted AWP ingredient cost excluding dispensing fees and ancillary <br />charges, and prior to application of Copayments) of applicable Prescription Drug <br />Claims for the annual period divided by total undiscounted AWP ingredient cost (both <br />amounts will be calculated as of the date of adjudication) for the annual period)]. <br />Discounted ingredient cost will be the lesser of MAC (as applicable), U&C or AWP <br />discount. <br />Notwithstanding anything herein to the contrary: (i) a Prescription Drug Claim that <br />processes at the Brand Drug rates (Participating Pharmacy Reimbursement Rates) and <br />(Mail Pharmacy Reimbursement Rates), as indicated on the ingredient cost field of tile <br />Prescription Drug Claim's data record, shall be reconciled as part of the Brand Drug <br />guarantee below, and (ii) a Prescription Drug Claim that processes at the Generic Drug <br />rates (Participating Pharmacy Reimbursement Rates) and (Mail Pharmacy <br />Reimbursement Rates) above, as indicated on the ingredient cost field of the <br />Prescription Drug Claim's data record, shall be reconciled as part of the Generic Drug <br />guarantee below. The Prescription Drug Claims that may be excluded from the <br />reconciliation of the pricing guarantees are as identified in the "Prescription Drug <br />Claims Excluded" paragraphs below in addition to Prescription Drug Claims <br />dispensed in Puerto Rico, Guam, Northern Mariana Islands, Virgin Islands, Hawaii, <br />Massachusetts, Alaska, West Virginia, and rural pharmacies. Furthermore, prices may <br />vary in certain states for reasons such as most favored nations laws, other state or local <br />legal requirements, geographic location, or other factors beyond the control of <br />Administrator. In those situations, some Claims may be exempt from reconciliation <br />of the financial guarantees set forth herein. All Claims may be aggregated for purposes <br />of such rates. Claims dispensed in states subject to NADAC or another pricing <br />benchmark required by law for pharmacy reimbursement may be excluded from <br />dispensing fee guarantees only. Additionally, under any retail pricing arrangement(s) <br />subject to NADAC pricing, Administrator will retrospectively invoice Client for the <br />difference between Client's contracted dispensing fee and any state mandated <br />pharmacy dispensing fee resulting from claims incurred in any state that mandates the <br />use of NADAC or another pricing benchmarks in pharmacy reimbursement. <br />NOT FOR DISTRIBUTION. THE INFORMATION CONTAINED HEREIN IS CONFIDENTIAL, PROPRIETARY <br />AND CONSTITUTES TRADE SECRETS OF ESI AND RXBENEFITS <br />
The URL can be used to link to this page
Your browser does not support the video tag.